Archive: biotech
New Pick: Invest in the Brilliant Minds Behind Billions of Dollars in Pharma Sales
By Andy Gordon on May 19, 2022
In a slightly less broken world, Enosi Life Sciences would not exist as is. Enosi is a tiny drug research and development company. And that is the only ordinary-sounding thing about it. Its technology is not ordinary. Its rockstar founders are far from ordinary. And its vision to create a new, more powerful and safer generation of autoimmune, anti-inflammation and cancer-fighting drugs is extraordinarily ambitious — and well within reach. Enosi is a product…
Startup Insider: Filling the Biopharma Funding Gap
By Early Investing on July 12, 2021
There’s a funding gap in medical research known as the “valley of death.” When research begins, it’s funded by government grants and nonprofits. But drug research and development is very time-intensive. It typically takes around 10 years to bring a drug to market — and nine…
New Pick: This Medtech Startup is Ahead of Its Time
By Andy Gordon on March 4, 2021
Deal Details Startup: InnaMed Security type: Future Equity Agreement (SAFE) Valuation (cap): $20 million (to increase to $25 million) Minimum investment: $100 Where to invest: Wefunder Deadline…
Startup Insider: Learn About Biotech Startups from Insiders
By Early Investing on March 1, 2021
If you’ve ever wanted to understand how really smart founders think — or how biotech startups operate — then this episode of Startup Insider is for you. Monogram Orthopaedics’ co-founders Ben Sexson and Dr. Doug Unis joined Andy Gordon and Vin Narayanan for a wide-ranging conversation about their…
Startup Insider: Making Smart Biotech Investments
By Early Investing on January 11, 2021
Seed stage investing in pharma and biotech companies is a little different than seed stage investing in other sectors. When pharma and biotech companies approach crowdfunders, they’re usually pre-clinical — which means that human trials haven’t begun yet. And they’re raising amounts of money that can’t possibly sustain…
How To Invest in Complex Concepts
By Adam Sharp on October 20, 2020
I sometimes get invited to participate in deals in areas I don’t understand well — like biotechnology. In almost all these cases, the science is over my head. So I generally don’t invest in startups that are in complex areas (for me). However, there are certain investors who I respect…
New Pick: Invest in Saving Millions of Lives
By Andy Gordon on August 31, 2020
DEAL DETAILS Startup: Biopact CT Security type: Common stock Valuation: $30 million Share price: $1.55 Minimum investment: $465 Where to invest: Equifund Deadline: February…
Medicine’s Future is a Good Investment
By Adam Sharp on August 14, 2020
As humans, we all have trillions of microbes that live in and on our bodies. The “germs” (bacteria, viruses, fungi) present in and on a person are collectively known as a microbiome. Growing up, many of us were taught that bacteria and…
Take Advantage of AngelList Funds
By Adam Sharp on January 28, 2020
There are unique fund opportunities on AngelList that can give you exposure to more than 200 top startups with a single investment. Here’s how to take advantage.